Technical Analysis for MDP - Medexus Pharmaceuticals Inc.

Grade Last Price % Change Price Change
F 1.750 -2.23% -0.040
MDP closed down 2.23 percent on Friday, February 16, 2024, on 47 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Calm After Storm Range Contraction -2.23%
NR7 Range Contraction -2.23%
Narrow Range Bar Range Contraction -2.23%
Lower Bollinger Band Walk Weakness -2.23%
Inside Day Range Contraction -2.23%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Medexus Pharmaceuticals Inc. Description

Medexus Pharmaceuticals Inc, formerly Pediapharm Inc, is a Canada-based company engaged in pharmaceutical business sector. The Company is a North American focused, specialty pharmaceutical business that operates through three segments: Medac Pharma USA, a fully integrated commercial infrastructure focused on auto-immune diseases in the United States; Medexus Pharma Canada, a fully integrated commercial infrastructure focused on auto-immune disease and pediatric diseases in Canada; and a Business Development function, which works to maintain its product pipeline. The Company's flag products are Rasuvo and Metoject, a formulation of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an allergy medication. The Company provides products for the healthcare professionals and patients.


Classification

Keywords: Health Infrastructure Healthcare Pharma Pipe Pharmaceutical Integrated Pipeline Disease Drugs Pharmaceuticals Diseases Arthritis Medication Cnx Nifty Pharmaceutical Business Sector Pharmaceutical Industry In China Rheumatoid Arthritis

Is MDP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.53
52 Week Low 1.12
Average Volume 67,238
200-Day Moving Average 2.142
50-Day Moving Average 2.244
20-Day Moving Average 2.253
10-Day Moving Average 2.052
Average True Range 0.202
RSI (14) 34.64
ADX 23.38
+DI 22.373
-DI 36.140
Chandelier Exit (Long, 3 ATRs) 2.236
Chandelier Exit (Short, 3 ATRs) 2.265
Upper Bollinger Bands 2.954
Lower Bollinger Band 1.552
Percent B (%b) 0.14
BandWidth 62.246
MACD Line -0.171
MACD Signal Line -0.083
MACD Histogram -0.0879
Fundamentals Value
Market Cap 25.29 Million
Num Shares 14.5 Million
EPS -0.66
Price-to-Earnings (P/E) Ratio -2.66
Price-to-Sales 0.84
Price-to-Book 3.19
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.900
Resistance 3 (R3) 1.900 1.850 1.875
Resistance 2 (R2) 1.850 1.812 1.850 1.867
Resistance 1 (R1) 1.800 1.788 1.775 1.800 1.858
Pivot Point 1.750 1.750 1.738 1.750 1.750
Support 1 (S1) 1.700 1.712 1.675 1.700 1.642
Support 2 (S2) 1.650 1.688 1.650 1.633
Support 3 (S3) 1.600 1.650 1.625
Support 4 (S4) 1.600